Cargando…

The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends

BACKGROUND: The incidence of non-Hodgkin’s lymphoma (NHL) has increased steadily over the past few decades. Elucidating its global burden will facilitate more effective disease management and improve patient outcomes. We explored the disease burden, risk factors, and trends in incidence and mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Yurou, Liu, Yingyue, Fang, Xiaosheng, Jiang, Yujie, Ding, Mei, Ge, Xueling, Yuan, Dai, Lu, Kang, Li, Peipei, Li, Ying, Xu, Hongzhi, Fan, Juan, Zhou, Xiangxiang, Wang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272809/ https://www.ncbi.nlm.nih.gov/pubmed/37333805 http://dx.doi.org/10.3389/fonc.2023.1059914

Ejemplares similares

Prognosis and complications of patients with primary gastrointestinal diffuse large B‐cell lymphoma: Development and validation of the systemic inflammation response index‐covered score
por: Chu, Yurou, et al.
Publicado: (2023)

Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma
por: Fang, Xiaosheng, et al.
Publicado: (2013)

Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress
por: Chu, Yurou, et al.
Publicado: (2021)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017
por: Sun, Haifeng, et al.
Publicado: (2022)

Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities
por: Liu, Yingyue, et al.
Publicado: (2021)

Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety
por: Zhai, Yujia, et al.
Publicado: (2021)

Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma
por: Zhou, Xiangxiang, et al.
Publicado: (2017)

Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study
por: Zhou, Linghui, et al.
Publicado: (2019)

Improved survival time trends in Hodgkin's lymphoma
por: Koshy, Matthew, et al.
Publicado: (2016)

Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin
por: Salati, Massimiliano, et al.
Publicado: (2014)

Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico
por: Hernandez-Ruiz, Eleazar, et al.
Publicado: (2021)

Clinical and Epidemiological Profile of Elderly Hodgkin’s Lymphoma in India
por: Sharma, Manish, et al.
Publicado: (2022)

Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use
por: Qu, Qingyuan, et al.
Publicado: (2019)

Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma
por: Lu, Tiange, et al.
Publicado: (2023)

Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?
por: Stienen, J. J. C., et al.
Publicado: (2015)

Complete Resolution of Tumor Burden of Primary Cardiac Non-Hodgkin's Lymphoma
por: Mauricio, Rina, et al.
Publicado: (2016)

Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma
por: Nuersulitan, Reyizha, et al.
Publicado: (2021)

The global burden and temporal trend of cancer attributable to high body mass index: Estimates from the Global Burden of Disease Study 2019
por: Zhi, Xing, et al.
Publicado: (2022)

Temporal trends in the burden of non-communicable diseases in countries with the highest malaria burden, 1990–2019: Evaluating the double burden of non-communicable and communicable diseases in epidemiological transition
por: Li, Zhuo, et al.
Publicado: (2022)

Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
por: Zhou, Xiangxiang, et al.
Publicado: (2020)

Clinical and epidemiologic characteristics of non Hodgkin’s lymphoma in Bedouins in the south of Israel
por: Levi, Itai, et al.
Publicado: (2013)

PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA.
por: Ben Sghaier, R., et al.
Publicado: (2022)

Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review
por: Zhang, Yujie, et al.
Publicado: (2022)

Bilateral Non-Hodgkin's Lymphoma of the Temporal Bone: A Rare and Unusual Presentation
por: Vaid, Sanjay, et al.
Publicado: (2016)

Primary Non-Hodgkin Lymphoma of the temporal bone: A rare case report
por: Kaoutar, Chaker, et al.
Publicado: (2021)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway
por: Chen, Xiaomin, et al.
Publicado: (2023)

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
por: Abeykoon, Jithma P., et al.
Publicado: (2019)

Epidemiological features and temporal trends of HIV-negative tuberculosis burden from 1990 to 2019: a retrospective analysis based on the Global Burden of Disease Study 2019
por: Chen, Yuqian, et al.
Publicado: (2023)

A 12-Year Comparative Analysis of Hodgkin and Non-Hodgkin Lymphomas in Lebanon: Trend Characteristics and 10-Year Projections
por: Abdel Sater, Ali H, et al.
Publicado: (2020)

Trends Analysis of Non-Hodgkin Lymphoma at the National, Regional, and Global Level, 1990–2019: Results From the Global Burden of Disease Study 2019
por: Cai, Wenwen, et al.
Publicado: (2021)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Pathobiology of Hodgkin Lymphoma
por: Agostinelli, Claudio, et al.
Publicado: (2014)

Cutaneous Hodgkin's lymphoma
por: Ambekar, Asawari Anant, et al.
Publicado: (2017)

Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry
por: Gurney, K A, et al.
Publicado: (1999)

ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
por: PETROIANU, Andy, et al.
Publicado: (2020)

PB2256: EPIDEMIOLOGY AND OUTCOMES OF HODGKIN LYMPHOMA IN URUGUAY. A NATIONAL REGISTRY
por: Oliver, Carolina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oe0925s8tagaa7mo2rvu01cmm8